173 related articles for article (PubMed ID: 20609181)
21. Clinical and immunological follow-up of pemphigus patients on adjuvant treatment with immunoadsorption or rituximab.
Pfütze M; Eming R; Kneisel A; Kuhlmann U; Hoyer J; Hertl M
Dermatology; 2009; 218(3):237-45. PubMed ID: 19088461
[TBL] [Abstract][Full Text] [Related]
22. Changes in desmoglein 1 expression and subcellular localization in cultured keratinocytes subjected to anti-desmoglein 1 pemphigus autoimmunity.
Cirillo N; Gombos F; Lanza A
J Cell Physiol; 2007 Feb; 210(2):411-6. PubMed ID: 17058228
[TBL] [Abstract][Full Text] [Related]
23. Detection of pemphigus desmoglein 1 and desmoglein 3 autoantibodies and pemphigoid BP180 autoantibodies in saliva and comparison with serum values.
Andreadis D; Lorenzini G; Drakoulakos D; Belazi M; Mihailidou E; Velkos G; Mourellou-Tsatsou O; Antoniades D
Eur J Oral Sci; 2006 Oct; 114(5):374-80. PubMed ID: 17026501
[TBL] [Abstract][Full Text] [Related]
24. Serum and salivary desmoglein 1 and 3 enzyme-linked immunosorbent assay in pemphigus vulgaris: correlation with phenotype and severity.
Hallaji Z; Mortazavi H; Lajevardi V; Tamizifar B; AmirZargar A; Daneshpazhooh M; Chams-Davatchi C
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):275-80. PubMed ID: 19709345
[TBL] [Abstract][Full Text] [Related]
25. Atypical pemphigus involving the esophagus with IgG antibodies to desmoglein 3 and IgA antibodies to desmoglein 1.
Inui S; Amagai M; Tsutsui S; Fukuhara-Yoshida S; Itami S; Katayama I
J Am Acad Dermatol; 2006 Aug; 55(2):354-5. PubMed ID: 16844530
[No Abstract] [Full Text] [Related]
26. Simultaneous immunolocalization of desmoglein 3 and IgG4 in oral pemphigus vulgaris: IgG4 predominant autoantibodies in its pathogenesis.
Abé T; Maruyama S; Babkair H; Yamazaki M; Cheng J; Saku T
J Oral Pathol Med; 2015 Nov; 44(10):850-6. PubMed ID: 25401705
[TBL] [Abstract][Full Text] [Related]
27. Salivary Samples for the Diagnosis of Pemphigus vulgaris Using the BIOCHIP Approach: a Pilot Study.
Russo I; Saponeri A; Michelotto A; Alaibac M
In Vivo; 2017 Jan; 31(1):97-99. PubMed ID: 28064226
[TBL] [Abstract][Full Text] [Related]
28. Endemic pemphigus foliaceus in the Peruvian Amazon.
Ortega-Loayza AG; Ramos W; Gutierrez EL; Jimenez G; Rojas I; Galarza C
Clin Exp Dermatol; 2013 Aug; 38(6):594-600. PubMed ID: 23692307
[TBL] [Abstract][Full Text] [Related]
29. Are desmoglein autoantibodies essential for the immunopathogenesis of pemphigus vulgaris, or just "witnesses of disease"?
Amagai M; Ahmed AR; Kitajima Y; Bystryn JC; Milner Y; Gniadecki R; Hertl M; Pincelli C; Kurzen H; Fridkis-Hareli M; Aoyama Y; Frusić-Zlotkin M; Müller E; David M; Mimouni D; Vind-Kezunovic D; Michel B; Mahoney M; Grando S
Exp Dermatol; 2006 Oct; 15(10):815-31. PubMed ID: 16984264
[TBL] [Abstract][Full Text] [Related]
30. In vitro pathogenicity assay for anti-desmoglein autoantibodies in pemphigus.
Ishii K; Amagai M
Methods Mol Biol; 2013; 961():219-25. PubMed ID: 23325646
[TBL] [Abstract][Full Text] [Related]
31. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins.
Ishii K; Amagai M; Hall RP; Hashimoto T; Takayanagi A; Gamou S; Shimizu N; Nishikawa T
J Immunol; 1997 Aug; 159(4):2010-7. PubMed ID: 9257868
[TBL] [Abstract][Full Text] [Related]
32. Atypical pemphigus with immunoglobulin G autoantibodies against desmoglein 3 and desmocollin 3.
Kamiya K; Aoyama Y; Wakashima C; Kudo T; Nakajima K; Sano S; Ishii N; Teye K; Hashimoto T; Iwatsuki K; Tokura Y
J Dermatol; 2016 Apr; 43(4):429-31. PubMed ID: 26331291
[TBL] [Abstract][Full Text] [Related]
33. The location of binding sites of pemphigus vulgaris and pemphigus foliaceus autoantibodies: a post-embedding immunoelectron microscopic study.
Zhou S; Ferguson DJ; Allen J; Wojnarowska F
Br J Dermatol; 1997 Jun; 136(6):878-83. PubMed ID: 9217820
[TBL] [Abstract][Full Text] [Related]
34. Immune dysregulation of pemphigus in humans and mice.
Yokoyama T; Amagai M
J Dermatol; 2010 Mar; 37(3):205-13. PubMed ID: 20507383
[TBL] [Abstract][Full Text] [Related]
35. Affinity immunoblotting studies on the restriction of autoantibodies from endemic pemphigus foliaceus patients.
Calvanico NJ; Swartz SJ; Diaz LA
J Autoimmun; 1993 Apr; 6(2):145-57. PubMed ID: 8499057
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of commercially available ELISA assays as a tool for monitoring and managing pemphigus patients: a prospective study.
Bracke S; Speeckaert R; Van Geel N; De Bacquer D; Lambert J
Eur J Dermatol; 2013; 23(1):33-9. PubMed ID: 23302186
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of desmoglein enzyme-linked immunosorbent assay (ELISA) in Indian patients with pemphigus vulgaris.
Sharma VK; Prasad HR; Khandpur S; Kumar A
Int J Dermatol; 2006 May; 45(5):518-22. PubMed ID: 16700783
[TBL] [Abstract][Full Text] [Related]
38. Pemphigus vegetans Neumann type with anti-desmoglein and anti-periplakin autoantibodies.
Cozzani E; Christana K; Mastrogiacomo A; Rampini P; Drosera M; Casu M; Murialdo G; Parodi A
Eur J Dermatol; 2007; 17(6):530-3. PubMed ID: 17951135
[TBL] [Abstract][Full Text] [Related]
39. The imbalance of Th17 and regulatory T cells in pemphigus patients.
Xu RC; Zhu HQ; Li WP; Zhao XQ; Yuan HJ; Zheng J; Pan M
Eur J Dermatol; 2013; 23(6):795-802. PubMed ID: 24192290
[TBL] [Abstract][Full Text] [Related]
40. Pemphigus herpetiformis: analysis of the autoantibody profile during the disease course with changes in the clinical phenotype.
Lebeau S; Müller R; Masouyé I; Hertl M; Borradori L
Clin Exp Dermatol; 2010 Jun; 35(4):366-72. PubMed ID: 19874319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
